Latest MSD News & Updates
See the latest news and media coverage for MSD. We track all announcements, press releases, and industry mentions in real time, all in one place.
Research-intensive biopharmaceutical company
msd.com- Headquarters
- Rahway, United States
- Company type
- Public company
- Number of employees
- 40,000+
Last updated
Latest news about MSD
In short: MSD completed the $5.8 billion acquisition of Terns Pharmaceuticals and reported strong Q1 2026 financial results with $16.3 billion in sales.
Company announcements
-
MSD states no material impact from Daiichi Sankyo's manufacturing update
MSD remains confident in their ADC collaboration's multibillion-dollar opportunity. Daiichi Sankyo handles manufacturing for most ADCs; MSD for gocatamig.
-
MSD scientists publish paper on biocatalytic synthesis of enlicitide decanoate
The Science publication details a scalable enzyme-based method for producing the investigational oral PCSK9 inhibitor, offering sustainability and manufacturing efficiencies.
-
MSD completes acquisition of Terns Pharmaceuticals
The deal adds TERN-701, an investigational BCR::ABL1 inhibitor for chronic myeloid leukemia, to MSD’s oncology pipeline. Transaction valued at $5.8 billion.
-
MSD appoints Dave Maraldo as EVP and president of MMD
He leads global manufacturing and supply operations and joins the Executive Team. Dave succeeds retiring Sanat Chattopadhyay.
Media coverage
-
MSD Lawyers Files Wrongful Death Lawsuit Following Death of 21-Year-Old Issac...
Los Angeles Employment & Personal Injury Attorneys Lawsuit filed in Los Angeles County Superior Court on behalf of decedent's mother, Heidi Coen Tragically, this is...
-
Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale...
Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate Publication in Science magazine outlines ...
-
MSD joins PD-1/VEGF push in cancer with LaNova deal
There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy. Now...
-
MSD concludes Terns acquisition to expand CML pipeline
Merck & Co (MSD) has completed its acquisition of Terns Pharmaceuticals, expanding its pipeline of...
Track MSD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
MSD competitors & trending companies
Browse news for competitors to MSD and other trending companies.
AstraZeneca
Lilly
Novartis
GSK
Sanofi
BMS
AbbVie
Merck
Pfizer
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics